2. Spillane J, Kullmann DM, Hanna MG. Genetic neurological channelopathies: molecular genetics and clinical phenotypes. J Neurol Neurosurg Psychiatry. 2016;87:37–48.
3. Ryan DP, Ptacek LJ. Episodic neurological channelopathies. Neuron. 2010;68:282–92.
4. Rogawski MA. Common pathophysiologic mechanisms in migraine and epilepsy. Arch Neurol. 2008;65:709–14.
5. Bauer PR, Carpay JA, Terwindt GM, et al. Headache and epilepsy. Curr Pain Headache Rep. 2013;17:351
6. Rajapakse T, Buchhalter J. The borderland of migraine and epilepsy in children. Headache. 2016;56:1071–80.
7. Bagnato F, Good J. The use of antiepileptics in migraine prophylaxis. Headache. 2016;56:603–15.
8. Headache Classification Committee of the International Headache Society, (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.
9. Cianchetti C, Pruna D, Ledda M. Epileptic seizures and headache/migraine: a review of types of association and terminology. Seizure. 2013;22:679–85.
10. Bernasconi A, Andermann F, Bernasconi N, Reutens DC, Dubeau F. Lateralizing value of peri-ictal headache: a study of 100 patients with partial epilepsy. Neurology. 2001;56:130–2.
11. Yankovsky AE, Andermann F, Bernasconi A. Characteristics of headache associated with intractable partial epilepsy. Epilepsia. 2005;46:1241–5.
12. Saitowitz Z, Flamini R, Berenson F. Ictal epileptic headache: a review of current literature and differentiation from migralepsy and other epilepsies. Headache. 2014;54:1534–40.
13. HELP Study Group. Multi-center study on migraine and seizure-related headache in patients with epilepsy. Yonsei Med J. 2010;51:219–24.
14. Kim DW, Sunwoo JS, Lee SK. Headache as an aura of epilepsy: video-EEG monitoring study. Headache. 2016;56:762–8.
15. Kwan P, Man CB, Leung H, Yu E, Wong KS. Headache in patients with epilepsy: a prospective incidence study. Epilepsia. 2008;49:1099–102.
16. Ito M, Adachi N, Nakamura F, et al. Characteristics of postictal headache in patients with partial epilepsy. Cephalalgia. 2004;24:23–8.
17. Verrotti A, Coppola G, Di Fonzo A, et al. Should “migralepsy” be considered an obsolete concept? a multicenter retrospective clinical/EEG study and review of the literature. Epilepsy Behav. 2011;21:52–9.
18. Sances G, Guaschino E, Perucca P, Allena M, Ghiotto N, Manni R. Migralepsy: a call for a revision of the definition. Epilepsia. 2009;50:2487–96.
19. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005–2009. Epilepsia. 2010;51:676–85.
20. Luders H, Acharya J, Baumgartner C, et al. Semiological seizure classification. Epilepsia. 1998;39:1006–13.
21. Luders H, Acharya J, Baumgartner C, et al. A new epileptic seizure classification based exclusively on ictal semiology. Acta Neurol Scand. 1999;99:137–41.
23. Parisi P, Striano P, Trenite DG, et al. ‘Ictal epileptic headache’: recent concepts for new classifications criteria. Cephalalgia. 2012;32:723–4.
24. Fanella M, Fattouch J, Casciato S, et al. Ictal epileptic headache as “subtle” symptom in generalized idiopathic epilepsy. Epilepsia. 2012;53:e67–70.
25. Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: A review of statistics from national surveillance studies. Headache. 2013;53:427–36.
27. Roh JK, Kim JS, Ahn YO. Epidemiological and clinical characteristics of migraine in Korea. J Korean Neurol Assoc. 1997;15:1–18.
29. Lipton RB, Ottman R, Ehrenberg BL, Hauser WA. Comorbidity of migraine: the connection between migraine and epilepsy. Neurology. 1994;44:10 Suppl 7. S28–32.
30. Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology. 1994;44:2105–10.
32. Mameniskiene R, Karmonaite I, Zagorskis R. The burden of headache in people with epilepsy. Seizure. 2016;41:120–6.
33. Belcastro V, Striano P, Parisi P. Interictal and periictal headache in patients with epilepsy: migraine-triggered seizures or epilepsy-triggered headache? Eur J Neurol. 2013;20:1333–4.
34. Belcastro V, Striano P, Parisi P. “Ictal epileptic headache”: beyond the epidemiological evidence. Epilepsy Behav. 2012;25:9–10.
36. Duchaczek B, Ghaeni L, Matzen J, Holtkamp M. Interictal and periictal headache in patients with epilepsy. Eur J Neurol. 2013;20:1360–6.
37. Ettinger AB, Devinsky O, Weisbrot DM, Goyal A, Shashikumar S. Headaches and other pain symptoms among patients with psychogenic non-epileptic seizures. Seizure. 1999;8:424–6.
38. Kasteleijn-Nolst Trenite D, Parisi P. Migraine in the borderland of epilepsy: “Migralepsy” an overlapping syndrome of children and adults? Epilepsia. 2012;53: Suppl 7. 20–5.
39. Sowell MK, Youssef PE. The comorbidity of migraine and epilepsy in children and adolescents. Semin Pediatr Neurol. 2016;23:83–91.
40. Fogarasi A, Janszky J, Tuxhorn I. Autonomic symptoms during childhood partial epileptic seizures. Epilepsia. 2006;47:584–8.
41. Foldvary-Schaefer N, Unnwongse K. Localizing and lateralizing features of auras and seizures. Epilepsy Behav. 2011;20:160–6.
43. Kelley SA, Hartman AL, Kossoff EH. Comorbidity of migraine in children presenting with epilepsy to a tertiary care center. Neurology. 2012;79:468–73.
44. Rho YI. Epidemiology and clinical characteristics of headache comorbidity with epilepsy in children and adolescents. Korean J Pediatr. 2007;50:672–7.
45. Caraballo R, Koutroumanidis M, Panayiotopoulos CP, Fejerman N. Idiopathic childhood occipital epilepsy of gastaut: A review and differentiation from migraine and other epilepsies. J Child Neurol. 2009;24:1536–42.
46. Berg AT, Shinnar S, Levy SR, Testa FM. Newly diagnosed epilepsy in children: presentation at diagnosis. Epilepsia. 1999;40:445–52.
47. Covanis A. Panayiotopoulos syndrome: a benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis. Pediatrics. 2006;118:e1237–43.
48. Panayiotopoulos CP, Michael M, Sanders S, Valeta T, Koutroumanidis M. Benign childhood focal epilepsies: Assessment of established and newly recognized syndromes. Brain. 2008;131:2264–86.
49. Panayiotopoulos CP. Visual phenomena and headache in occipital epilepsy: a review, a systematic study and differentiation from migraine. Epileptic Disord. 1999;1:205–16.
50. Wirrell EC, Hamiwka LD. Do children with benign rolandic epilepsy have a higher prevalence of migraine than those with other partial epilepsies or nonepilepsy controls? Epilepsia. 2006;47:1674–81.
51. Goldin AL. Resurgence of sodium channel research. Annu Rev Physiol. 2001;63:871–94.
52. McCormick DA, Contreras D. On the cellular and network bases of epileptic seizures. Annu Rev Physiol. 2001;63:815–46.
53. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011;17:439–47.
54. Dreier JP, Major S, Pannek HW, et al. Spreading convulsions, spreading depolarization and epileptogenesis in human cerebral cortex. Brain. 2012;135:259–75.
55. Grunwald IQ, Kuhn AL, Schmitt AJ, Balami JS. Aneurysmal SAH: current management and complications associated with treatment and disease. J Invasive Cardiol. 2014;26:30–7.
57. Gorji A, Speckmann EJ. Spreading depression enhances the spontaneous epileptiform activity in human neocortical tissues. Eur J Neurosci. 2004;19:3371–4.
58. Kruger H, Luhmann HJ, Heinemann U. Repetitive spreading depression causes selective suppression of GABAergic function. Neuroreport. 1996;7:2733–36.
59. Coppola G, Schoenen J. Cortical excitability in chronic migraine. Curr Pain Headache Rep. 2012;16:93–100.
60. Goadsby PJ. The vascular theory of migraine--a great story wrecked by the facts. Brain. 2009;132:6–7.
61. Mulleners WM, Chronicle EP, Palmer JE, Koehler PJ, Vredeveld JW. Visual cortex excitability in migraine with and without aura. Headache. 2001;4:565–72.
62. Prontera P, Sarchielli P, Caproni S, et al. Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications. Cephalalgia. 2017;333102416686347. [Epub ahead of print].
63. Rubinstein M, Westenbroek RE, Yu FH, et al. Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of dravet syndrome. Neurobiol Dis. 2015;73:106–17.
65. Ebrahimi-Fakhari D, Saffari A, Westenberger A, Klein C. The evolving spectrum of PRRT2-associated paroxysmal diseases. Brain. 2015;138:3476–95.
67. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6. CD010611
68. Mulleners WM, McCrory DC, Linde M. Antiepileptics in migraine pro-phylaxis: an updated Cochrane review. Cephalalgia. 2015;35:51–62.
69. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6. CD010610
70. Parisi P. Why is migraine rarely, and not usually, the sole ictal epileptic manifestation? Seizure. 2009;18:309–12.